Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epstein-Barr Virus Proteins are a collection of proteins encoded by the Epstein-Barr virus (EBV), a herpesvirus associated with various malignancies and diseases. These proteins play crucial roles in viral replication, latency, immune evasion, and host cell transformation. Examples include the SM protein (a posttranscriptional regulator), glycoproteins gH/gL (involved in membrane fusion), EBNA1 (essential for latent-phase DNA replication), and BNRF1 (a major tegument protein and immune target). Targeting these proteins is of interest for developing antiviral therapies and immunotherapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epstein-Barr Virus Protein (EBV Protein).